Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 374041 - 374060 out of 488877 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Saudi Arabia | (A16AA05) carglumic acid (adm: O) | CARBAGLU 200MG DISPERSIBLE TABLETS | 5 Bottle, 200 mg, Oral use, Dispersible tablet, 200mg , Bottle, Dispersible tablet | Retail price without vat |
$0-0 |
$0-0 |
Amino Acid Metabolism, Inborn Errors; Propionic Acidemia | RecordatiRareDiseases / LaboratoiresBTT |
| Saudi Arabia | (A16AB03) agalsidase alfa (adm: P) | REPLAGAL 1mg/ml concetrate for solution for infusion | 1 Vial, 3,5ml, 1 mg/ml, Intravenous use, Concentrate for solution for infusion, 1mg/ml , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Fabry Disease | TakedaPharmaceuticalsInternationalAG / CangeneBioPharmaInc.(CBI) |
| Saudi Arabia | (A16AB05) laronidase (adm: P) | ALDURAZYME 100 U/ML VIAL | 1 Vial, 5ml, 100 U, Intravenous use, Concentrate for solution for infusion, 100U , Vial, Concentrate for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Mucopolysaccharidosis I | GENZYMEEUROPEB.V. / VETTERPHARMA-FERTIGUNGGMBH&CO.KG |
| Saudi Arabia | (A16AB10) velaglucerase alfa (adm: P) | VPRIV 40 U POWDER FOR SOLUTION FOR INFUSION | 1 Vial, 400 U, Intravenous use, Powder for solution for infusion, 400U , Vial, Powder for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
Gaucher Disease | TakedaPharmaceuticalsInternationalAG / CangeneBioPharmaInc.(CBI) |
| Saudi Arabia | (A16AB13) asfotase alfa | STRENSIQ | 12 Vial, 40 mg/ml, Subcutaneous use, Solution for injection, 40mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Hypophosphatasia | AlexionEuropeSAS / AlexionPharmaInternationalOperationsUnlimitedCompany |
| Saudi Arabia | (A16AB13) asfotase alfa | STRENSIQ | 12 Vial, 40 mg/ml, Subcutaneous use, Solution for injection, 40mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Hypophosphatasia | AlexionEuropeSAS / AlexionPharmaInternationalOperationsUnlimitedCompany |
| Saudi Arabia | (A16AB13) asfotase alfa | STRENSIQ | 12 Vial, 100 mg/ml, Subcutaneous use, Solution for injection, 100mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Hypophosphatasia | AlexionEuropeSAS / AlexionPharmaInternationalOperationsUnlimitedCompany |
| Saudi Arabia | (A16AB13) asfotase alfa | STRENSIQ | 12 Vial, 1ml, 40 mg/ml, Subcutaneous use, Solution for injection, 40mg/ml , Vial, Solution for injection | Retail price without vat |
$0-0 |
$0-0 |
Hypophosphatasia | AlexionEuropeSAS / AlexionPharmaInternationalOperationsUnlimitedCompany |
| Saudi Arabia | (A16AB15) velmanase alfa (adm: P) | Lamzede | 1 Vial, 5ml, 10 mg, Intravenous use, Powder for solution for infusion, 10mg , Vial, Powder for solution for infusion | Retail price without vat |
$0-0 |
$0-0 |
alpha-Mannosidosis | CHIESIFARMACEUTICIS / CHIESIFARMACEUTICIS |
| Saudi Arabia | (A16AX) various alimentary tract and metabolism products | SODIUM PHENYLACETATE AND SODIUM BENZOATE INJECTION | 1 Vial, 50ml, 10,10 %, Intravenous use, Injection, 10,10% , Vial, Injection | Retail price without vat |
$0-0 |
$0-0 |
n/a | NavintaLLC / UniversityofIowaPharmaceuticals |
| Saudi Arabia | (A16AX04) nitisinone (adm: O) | ORFADIN 10 MG CAPSULE | 60 Bottle, 10 mg, Oral use, Capsule, hard, 10mg , Bottle, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
Tyrosinemias | SWEDISHORPHANBIOVITRUMINTERNATIONALAB / APOTEKPRODUKTION&LABORATORIERAB |
| Saudi Arabia | (A16AX04) nitisinone (adm: O) | ORFADIN 2 MG CAPSULE | 60 Bottle, 2 mg, Oral use, Capsule, hard, 2mg , Bottle, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
Tyrosinemias | SWEDISHORPHANBIOVITRUMINTERNATIONALAB / APOTEKPRODUKTION&LABORATORIERAB |
| Saudi Arabia | (A16AX04) nitisinone (adm: O) | ORFADIN 20 MG CAPSULE | 60 Bottle, 20 mg, Oral use, Capsule, hard, 20mg , Bottle, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
Tyrosinemias | SWEDISHORPHANBIOVITRUMINTERNATIONALAB / APOTEKPRODUKTION&LABORATORIERAB |
| Saudi Arabia | (A16AX04) nitisinone (adm: O) | ORFADIN 5 MG CAPSULE | 60 Bottle, 5 mg, Oral use, Capsule, hard, 5mg , Bottle, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
Tyrosinemias | SWEDISHORPHANBIOVITRUMINTERNATIONALAB / APOTEKPRODUKTION&LABORATORIERAB |
| Saudi Arabia | (A16AX04) nitisinone (adm: O) | NITYR 2 mg Tablet | 60 Bottle, 2 mg, Oral use, Tablet, 2mg , Bottle, Tablet | Retail price without vat |
$0-0 |
$0-0 |
Tyrosinemias | CyclePharmaceuticalsLTD / RivopharmSA |
| Saudi Arabia | (A16AX04) nitisinone (adm: O) | NITYR 5 mg Tablet | 60 Bottle, 5 mg, Oral use, Tablet, 5mg , Bottle, Tablet | Retail price without vat |
$0-0 |
$0-0 |
Tyrosinemias | CyclePharmaceuticalsLTD / RivopharmSA |
| Saudi Arabia | (A16AX04) nitisinone (adm: O) | NITYR 10 mg Tablet | 60 Bottle, 10 mg, Oral use, Tablet, 10mg , Bottle, Tablet | Retail price without vat |
$0-0 |
$0-0 |
Tyrosinemias | CyclePharmaceuticalsLTD / RivopharmSA |
| Saudi Arabia | (A16AX10) eliglustat (adm: O) | CERDELGA | 56 Blister, 84 mg, Oral use, Capsule, hard, 84mg , Blister, Capsule, hard | Retail price without vat |
$0-0 |
$0-0 |
Gaucher Disease | GENZYMEEUROPEB.V. / GENZYMEIRELANDLIMITED |
| Saudi Arabia | (A16AX12) trientine (adm: O, expressed as trientine) | Cuprior | 72 Blister, 150 mg, Oral use, Film-coated tablet, 150mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Hepatolenticular Degeneration | Orphalan / DELPHARMEVREUX |
| Saudi Arabia | (A16AX15) telotristat (adm: O) | Xermelo | 90 Blister, 250 mg, Oral use, Film-coated tablet, 250mg , Blister, Film-coated tablet | Retail price without vat |
$0-0 |
$0-0 |
Carcinoid Tumor; Neuroendocrine Tumors | IPSENPHARMA / CATALENT |
Pages
